The customer received questionable high elecsys anti-ccp immunoassay results for one patient compared to other methodologies.On (b)(6) 2017, the anti-ccp result from a cobas 6000 e 601 module was 163.6 u/ml.Based on this result, the patient was diagnosed with an autoimmune disease.Sample 1 drawn on (b)(6) 2017 was tested on a quantalyser 160 (elisa) on (b)(6) 2017 and had a result of 3.35 units.This result was believed to be incorrect and the customer asked the patient to repeat the anti-ccp testing.Sample 2 was drawn on (b)(6) 2017.The result from the quantalyser 160 (elisa) on (b)(6) 2017 was 0.00 units.An aliquot of the same sample was tested on siemens centaur (clia) on (b)(6) 2017 and the result was <0.40 u/ml.An aliquot of the same sample was tested on a cobas 6000 e 601 module on (b)(6) 2017 and the result was 146.40 u/ml.The results were reported outside of the laboratory.There was no allegation of an adverse event.The serial numbers of the involved cobas 6000 e 601 modules were requested but were not provided.
|